Saint Louis, Missouri 63110

  • Spinal Cord Injury


Nerve Transfer surgery can provide improved hand function following cervical spinal cord injuries

Study summary:

Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of life and long-term functional independence will provide a significant public health impact. Specific Aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete cervical spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and optimal timing the the surgery. Hypothesis: Peripheral nerve transfers in patients with spinal cord injuries will improve hand function and provide improvement in patient quality of life and functional independence.


Inclusion Criteria: 1. 18-65 years of age 2. Informed Consent Document (ICD) signed by patient 3. Cervical spinal cord injury resulting in arm & hand functional impairment, with at least preserved elbow function 4. International Classification of Surgery of the Hand in Tetraplegia (ICSHT) category 0 - 4 5. Patients with a stable American Spinal Injury Association (ASIA) grade of A, B, or C, or with a diagnosis of central cord syndrome, showing minimal to no evidence of functional improvement in motor examination after at least 6 months of non-operative therapy post-injury 6. Appropriate candidate for nerve transfer study 7. Willing and able to comply with the study protocol 8. < 48 months from injury Exclusion Criteria: 1. Active infection at the operative site or systemic infection 2. Any return or ongoing clinical recovery of distal motor function within 6 months after injury 3. Physically or mentally compromised 4. Currently undergoing long-term steroid therapy 5. Significant joint contractures and/or limitations in passive range of motion in the arm or hand 6. Active malignancy 7. Systemic disease that would affect the patient's welfare or the research study 8. Pregnant 9. Immunologically suppressed or immunocompromised 10. Significant pain or hypersensitivity 11. Previous or current injury preventing use of tendon transfers to restore upper extremity function 12. Affective disorder of a degree that would make outcome assessment and study participation difficult 13. History of brachial plexus injury or systemic neuropathic process



Primary Contact:

Principal Investigator
Wilson Z Ray, MD
Washington University School of Medicine

Backup Contact:


Location Contact:

Saint Louis, Missouri 63110
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: June 23, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.